Boji Medical reports nine-month revenue growth of 25.24%
Regulatory / securities filing · 博济医药 / 巨潮资讯 CNinfo
Source published: · Event / reporting date: 2026-09-30
Site published: 2026-11-03 · Updated: 2026-11-03
This source is linked automatically. Choose a question to get started.
What changed
Boji Medical reported consolidated revenue of RMB0.732 billion, up 25.24%, and attributable net income of RMB49.3 million for the nine months ended September 30, 2026. Attributable net income increased 124.95%, while net operating cash flow was negative RMB9.6 million over the period. The quarterly filing is unaudited and covers the year-to-date period.
Why it may matter
Clinical-service growth and collections warrant joint monitoring, since higher reported profit does not automatically mean that operating cash flow has improved.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections